BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $536,550 | +245.5% | 10,684 | +334.8% | 0.01% | +300.0% |
Q2 2023 | $155,282 | +105.2% | 2,457 | +46.1% | 0.00% | +100.0% |
Q1 2023 | $75,673 | +28.2% | 1,682 | +24.9% | 0.00% | 0.0% |
Q4 2022 | $59,012 | -42.1% | 1,347 | -12.8% | 0.00% | -50.0% |
Q3 2022 | $102,000 | +52.2% | 1,544 | +17.2% | 0.00% | +100.0% |
Q2 2022 | $67,000 | +71.8% | 1,317 | +113.5% | 0.00% | 0.0% |
Q1 2022 | $39,000 | +200.0% | 617 | +414.2% | 0.00% | – |
Q4 2021 | $13,000 | +8.3% | 120 | 0.0% | 0.00% | – |
Q3 2021 | $12,000 | -88.8% | 120 | -90.1% | 0.00% | -100.0% |
Q2 2021 | $107,000 | -100.0% | 1,211 | -61.8% | 0.00% | -33.3% |
Q1 2021 | $308,220,000 | +513600.0% | 3,170 | +492.5% | 0.00% | +200.0% |
Q4 2020 | $60,000 | +11.1% | 535 | -7.8% | 0.00% | 0.0% |
Q3 2020 | $54,000 | +200.0% | 580 | +146.8% | 0.00% | 0.0% |
Q2 2020 | $18,000 | -33.3% | 235 | -50.5% | 0.00% | 0.0% |
Q1 2020 | $27,000 | -56.5% | 475 | -39.5% | 0.00% | -50.0% |
Q4 2019 | $62,000 | – | 785 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |